Psychedelics set to be the revolutionary treatments in pscyhiatry - Thelansis Knowledge Partners
Availability of psychedelic(s) with few administrations in a year and offering high remission rate could change the treatment pathway for these patients."
- Availability of psychedelic(s) with few administrations in a year and offering high remission rate could change the treatment pathway for these patients."
- According to an interviewed U.S.-based neurologist by Thelansis – "We desperately need disease-modifying treatments for many neurodegenerative conditions.
- As psychedelics would be beneficial for treatment-nonresponders or severe patients, the commercial opportunities are multiple for in-pipeline psychedelic therapies.
- What is the probable opportunity for Psychedelics (e.g., psilocybin, MDMA) to address the unmet needs of other TAs?